Xilio Therapeutics, Inc. Common Stock

XLONASDAQ • USD
7.55 USD
↘ 0.16 (2.01%)🟢LIVE (AS OF 02:24 PM EST)
🟢Market: OPEN

XLO is currently priced at $7.55. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bullish Golden Cross on the moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Nov 16, 2026.

Open?$7.85
High?$8.15
Low?$7.55
Prev. Close?$7.70
Volume?1.9K
Avg. Volume?13.8K
VWAP?$7.76
Rel. Volume?0.13x
Bid / Ask
Bid?$6.27 × 100
Ask?$8.90 × 100
Spread?$2.63
Midpoint?$7.59
Valuation & Ratios
Market Cap?54.4M
Shares Out?7.1M
Float?4.0M
Float %?60.3%
P/E Ratio?N/A
P/B Ratio?0.80
EPS?-$1.63
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.
Employees
76
Market Cap
54.4M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-10-22
Address
828 WINTER STREET
WALTHAM, MA 02451
Phone: 617-833-1027
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
27
Short Sent.?
28
Piotroski F-Score?2/9Weak
Altman Z-Score?-3.80Distress
Confidence?66%Moderate
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?9.65%Elevated
Short Interest?382.8K
Days to Cover?20.3
Free Float4.0M
Avg Daily Volume18.9K
Settlement Date2026-10-30
Financial Health
Current Ratio?4.72Strong
Quick Ratio?4.72Strong
Cash Ratio?4.56Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.80CHEAP▾
P/S?
Peers
100
S&P
87
0.99CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
1.7CHEAP▾
EV/Sales?
S&P
97
-1.23CHEAP▾
Returns & Efficiency
ROE?
S&P
8
-16.8%WEAK▾
ROA?
S&P
3
-8.5%WEAK▾
Cash Flow & Enterprise
FCF?$-57625000
Enterprise Value?$-67789339
Fundamentals ratios updated end of day